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ackground: In a previous report, we showed that Vibrio shilonii was found on whiteleg shrimp (Litopenaeus 
vannamei) with acute hepatopancreatic necrosis disease in Thua Thien Hue province, Vietnam. This 
study was performed to develop a diagnostic molecular marker generated by random amplified 
polymorphic DNA (RAPD) for V. shilonii rapid detection. 
Methods: Pathogen Vibrio spp. were isolated from shrimps and fishes, and were identified by 16S rRNA 
sequencing. Genetic diversity of Vibrio strains was analysis by RAPD technique. Specific PCR product for V. 
shilonii was cloned and sequenced. SCAR marker was developed from specific PCR product. 
Result: Twenty random primers were evaluated for RAPD to identify DNA polymorphisms between Vibrio 
species. The random primer OPN-06 generated a 468-bp DNA fragment specific for V. shilonii. This was then 
converted into a sequence-characterized amplified region (SCAR) marker designated N6-441.  
Conclusion: Specific primers (Vshi-441F/Vshi-441R) amplified a unique DNA fragment in all V. shilonii isolates 
but not in the other Vibrio spp. This PCR assay showed significantly sensitive to the target DNA and reliably for 
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Introduction  
Whiteleg (Litopenaeus vannamei) is the most popular 
shrimp species for commercial cultivation due to their 
survival advantages, fast growth rate and strong 
adaptability to environment [1]. The shrimp is currently 
cultivated in various areas in the world including 
Southeast Asia, China, India, United States, Mexico, and 
Latin America countries. Shrimp industry produced more 
than 4 million tons in 2016 [2]. Whiteleg and black tiger 
(Penaeus monodon) shrimps are the most common 
farm‐based shrimp species cultured in Vietnam [3]. 
However, the diseases are highly occurred and directly 
affected to shrimp farming industry [4]. 
Thua Thien Hue is a province that is located in Central 
of Vietnam. It has a biggest lagoon in the Southeast Asia 
(Tam Giang lagoon) which plays significantly importance 
role in the aquaculture farming industry. Aquaculture has 
been developing in Thua Thien Hue province for 50 
years ago and became the most important livelihood 
activity. However, aquaculture productivity decreased 
continuously since 2009 until now. The main reason is 
because of the disease outbreak, natural disasters, 
climate change and the environment issues, especially 
water pollution, impacting on the health of aquatic 
animals. Many farmers lost their production due to the 
bloom of pathogenic Vibrio sp. and viral shrimp diseases 
related to increasing water temperature [5]. 
In 2009, acute hepatopancreatic necrosis disease 
(AHPND) has caused remarkable mortality (up to 100%) 
in populations of shrimp cultured in South East Asia and 
Latin America countries. This disease is referred to as 
early mortality syndrome (EMS). AHPND is caused by 
several Vibrio species, which carry out the genes encode 
for toxic proteins  similar to Photorhabdus insect-related 
(Pir) toxins [6,7]. The marine bacterium Vibrio shilonii 
was firstly identified in the coastal areas of the 
Mediterranean Sea and has been proposed as the agent 
factor causing the bleaching disease for Oculina 
patagonica [8]. It was recently reported that V. shilonii 
caused the acute hepatopancreatic necrosis disease 
(AHPND) on shrimp in Ecuador and Vietnam [5,7].  
Random amplified polymorphic DNA (RAPD) is rapid 
and powerful tool for generating molecular markers to 
differentiate organism population. However, RAPD is 
limited by inherent low reliability and reproducibility of the 
PCR reaction. Thus, a RAPD-derived codominant and 
reproducible marker was developed and called as the 
sequence-characterized amplified region (SCAR) [9]. 
Using SCAR markers for identification of pathogens such 
as Pseudomonas syringae [10], Pseudofabraea 
citricarpa [11], and Bipolaris sorokiniana [12]. However, 
SCAR markers to identify Vibrio species have not been 
previously reported. 
In Thua Thien Hue, five strains of V. shilonii were 
found on whiteleg shrimp with AHPND [5]. However, no 
more information of these five strains has been 
published. This study aimed to develop a molecular 
marker for the rapid V. shilonii identification and to 
provide scientific data as the basis for the study, and to 
contribute to the production of rapid diagnostic kits for 
pathogens Vibrio in the future.    
Methods 
Vibrio strains 
Vibrio strains were provided by the Laboratory of Gene 
Technology, Institute of Biotechnology, Hue University, 
Vietnam (Table 1). Characteristics of each strain were 
previously described [5]. 
DNA isolation 
Vibrio colonies were cultured in alkaline saline peptone 
water medium with 2% peptone and 2% NaCl, pH 8.6, 
with shaking at 180 rpm for 18 h at 30°C. Cells were 
collected using centrifugation with 13,000 rpm at 4°C for 
1 min. Total genomic DNA was extracted by the 
AquaPure Genomic DNA Isolaton Kit (Cat. 732-6340, 
Bio-rad) according to the manufacturer’s 
recommendations, and stored at 4°C. Total DNA 
concentrations were determined using a photo 
spectrometer at 260/280 nm. Genomic DNA was 
adjusted to final concentration of 50 ng/µL for PCR 
amplification. 
RAPD analysis 
Genomic DNA pools of each species were used as 
templates for RAPD analysis (Table 1). DNA pool 
samples were prepared by mixing genomic DNA of all 
strains from each species into one unique sample with 
an equal ratio. A total of 20 RAPD primers (Operon 
Technologies, USA) were assayed for detecting Vibrio 
shilonii species (Table 2), these primers were used in our 
previous study [5] of randomly selected. Specific bands 
(absent in the other Vibrio species) were replicated twice 
for confirmation used for further studies. PCR-RAPD 
reactions were carried out according to Quang et al. [5]. 
DNA pool 
codes 











N2 Vibrio shilonii 5 VT23, VT26, 
VT27, VT29, 
VT33 
N3 Vibrio vulnificus 6 VC15, VC17, 
VC21, VC28, 
VC37, VC67 
N4 Vibrio harveyi 3 VC24, VC25, 
VC45 
N5 Vibrio cholera 3 VC43, VC53, 
VC61 
N6 Vibrio communis 1 VT47 
N7 Vibrio furnissii 1 VT65 
N8 Vibrio brasiliensis 1 VC52 
Table 1: DNA pool of Vibrio samples [5]. 
DNA fragment cloning and sequencing 
The specific amplicon of V. shilonii was extracted, then 
purified with GeneJET Gel Extraction Kit (Thermo 
Scientific, Lithuania). The purified PCR product was 
cloned into pGEM-T Easy vector (Promega, USA) and 
transferred into Escherichia coli strain TOP10 competent 
cells heat shock method [13]. Positive clones were 
confirmed by PCR with M13 primers and sequenced at 
Firstbase company (Malaysia). 
SCAR marker development
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Specific SCAR primers Vshi-441F and Vshi-441R were 
designed based on the sequenced RAPD amplicon 
(Table 3). Genomic DNA samples, including those from 
five V. shilonii strains and other pathogen Vibrio species, 
were amplified using the Vshi-441F and Vshi-441R 
primers to verify the SCAR marker specificity. A 12 μL 
PCR reaction system was developed containing 50 ng of 
total DNA, 10 pmol of each primer, 6 µL 2× GoTaq® 
Green Master Mix (Promega, USA), and sterile distilled 
water. PCR amplification was performed as follows: 
95°C for 5 min; 35 cycles at 95°C for 1 min, 55°C for 1 
min, and 72°C for 1 min; the final cycle at 72°C for 10 
min. 
To test detection sensitivity, 0.01–10 ng/μL of diluted 
genomic DNA of V. shilonii were evaluated as DNA 















OPA-01 CAGGCCCTTC 1 0 - 
OPA-02 TGCCGAGCTG 3 1 A02-350 
OPA-03 AGTCAGCCAC 3 0 - 
OPA-09 GGGTAACGCC 5 1 A09-2000 
OPA-11 CAATCGCCGT  2 2 A11-850 
and A11-
500 
OPB-01 GTTTCGCTCC 2 1 B01-1200 
OPB-04 GGACTGGAGT 5 1 B04-1600 
OPB-18 CCACAGCAGT 2 1 B18-250 
OPC-13 AAGCCTCGTC 0 0 - 
OPD-02 GGACCCAACC 6 1 D02-1200 
OPD-07 TTGGCACGGG 1 0 - 
OPD-11 AGCGCCATTG 3 1 D11-1400 
OPF-04 GGTGATCAGG 4 0 - 
OPF-08 GGGATATCGG 0 0 - 
OPG-06 GTGCCTAACC 0 0 - 
OPG-10 AGGGCCGTCT 1 1 G10-750 
OPG-17 ACGACCGACA 3 0 - 
OPK-13 GGTTGTACCC 2 0 - 
OPN-03 GGTACTCCCC 2 1 N03-900 
OPN-06 GAGACGCACA 1 1 N06-450 
Total 46 12 
Table 2: RAPD primer selection for Vibrio shilonii.  
Results 
RAPD analysis 
To reduce the number of test samples, we used a DNA 
pool instead of individual genomic DNA for specific 
RAPD amplicons. The DNA pool in this study was a 
mixture of genomic DNA of strains of each Vibrio species 
at an equal ratio: eight DNA pool samples for V. 
parahaemolyticus, V. vulnificus, V. shilonii, V. cholera, V. 
communis, V. harveyi, V. furnissii, and V. brasiliensis 
(Table 1). 
From 20 tested random primers, we obtained 46 DNA 
fragments from Vibrio shilonii (0–6 DNA bands/primer); 
most of these were polymorphic bands (Figure 1). 
Twelve specific bands for V. shilonii were generated from 
11 primers (Table 2), and these primers were used for  
 
Figure 1. Representative specific DNA bands from PCR-RAPD 
with a DNA pool template. M. DNA molecular size marker 
(GeneRulerTM DNA 1 kb ladder, Thermo Fisher Scientific). White 
arrows indicate specific bands. (A) OPA-11 and OPB-01 primers. 
(B) OPB-04 and OPB-18 primers. (C) OPN-06 and OPD-02 primers. 
 
Figure 2: RAPD profile of Vibrio spp. with selected primer. M. 
DNA molecular size marker (GeneRulerTM DNA 1 kb ladder, 
Thermo Fisher Scientific). White arrows indicate the specific 
bands. (A) Primer OPA-11. (B) Primer OB-18. (C) Primer OPN-06. 
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N06_468         GAGACGCACATAAGGTAAGTGCAGATTGTTACGCGGAAAATGTCGGTTCTTACAAAACTC 
CP009355        TTAAGGCGCATAAAGTCAGTGCAGATTGCTACTCATCGAATGTGGGTTCATACAAAACGT 
CP025797        TAAACGCCCATAAAGTCAGTGCCGATTGCTACGCTTCTAATGTTGGTTCTTACAAGACGT 
CP025793        TAAACGCCCATAAAGTCAGTGCCGATTGCTACGCTTCTAATGCTGGCTCTTACAAGACGT 
CP013485        TAAACGCCCATAAAGTCAGTGCGGATTGCTACGCTTCTAATGCTGGTTCTTACAAAACGT 
                   * ** ***** ** ***** ***** *** *    ****  ** ** ***** **   
 
N06_468         TTGAGAAGTGTGGCTTCGTTCAGGAAGGACGTCAGAAAGACTACTATAAGCTTGAGCACG 
CP009355        TAGAGAAATGCGGCTTTAGCCAAGAAGGACGTCAGACAGACTATTACAAGCTAGAGGAAG 
CP025797        TAGAGAAAAATGGTTTTACTCAAGAAGGCCGTCAGAAAGACTACTACAAACTAGAGCAAG 
CP025793        TAGAGAAAAATGGTTTTACTCAGGAAGGCCTTCAGAAAGACTACTATAAACGAGAGCAAG 
CP013485        TAGAGAAAAATGGTTTTACTCAAGAAGGCCGTCAGAAAGACTACTACAAACGAGAGCAAG 
                * *****    ** **    ** ***** * ***** ****** ** ** *  *** * * 
 
N06_468         GTTTTGATGACGAGCTCTATTATGGCATGACAGCCGAGCAGTTCAGTGCATTAAACCGCT 
CP009355        GCTTGGAAGACAAGCTTTACTACGGTATGACAGCAGAGCAATTCGCCTCTTTCAATCGTT 
CP025797        GCTTTGACGACAAGCTTTACTACGGTATGACCGCAGAACAATTCGCGTCTTTAAATCGCT 
CP025793        GCTTTGACGATAAACTTTACTACGGTATGACCGCAGAGCAATTCGCGTCTTTAAATCGCT 
CP013485        GCTTTGACGACAAGCTTTACTACGGCATGACCGCAGAACAATTCGCGTCTTTAAATCGCT 
                * ** ** **  * ** ** ** ** ***** ** ** ** ***    * ** ** ** * 
 
N06_468         -----------GATAAAGC---------------------------AAAAGGCCGTTAAA 
CP009355        TAG-------TGATCAAGCGACGCGTTTAAACAGC------AAACGAAAAGGCCGCTA-- 
CP025797        AATAATTAGCTGACAAAAAAGTAGCTAACAACAACGTAGCCAACAAAAAAGGCCGTTAA- 
CP025793        GATTATTAGCCGACAAAAAAGTAGCTAAAAACAAAGTAGTGAACAAAAAAGGCCGTTAA- 
CP013485        AATAATTAGCTAACAAA------------------------------AAAGGCCGTTAA- 
                            *  **                              ******** **   
 
N06_468         CACCTTAGTCGGATTTAACGGCCTTTT-TGTATCAAGTG--------------CTTAGTT 
CP009355        TGCCCAAGATCGGGTTAGCGGCCTTTTCTATATTAATAGACC-----CTAGGTCTTAGTT 
CP025797        CCCACATGCTCGGGTTAACGGCCTTTTCTATATTCAGCGCTAAATGGCTAAGACTTAGTT 
CP025793        CCCACATGCTCGGGTTAACGGCCTTTTCTATATTCAGCGCTAAATGGCTAAGACTTAGTT 
CP013485        CCCAAATGCTCGGGTTAACGGCCTTTTCTATATTCAGCGCTAAATGGCAAAGGCTTAGTT 
                  *    *   *  *** ********* * ***  *  *              ******* 
 
N06_468         AGCCTGGCTCTGGCTCTGAAGCTTCTCTTTCGCTTCTTCAACTTTTGAGAAGTCCAATCC 
CP009355        GCCTTGATTTTGGCTTTGAAGCTTCTCTTTTGCTTCTTCAACTTTTGAGAAATCTAAACC 
CP025797        GCCTTGGTTTTGGCTTTGAAGCTTCTCTTTTGCTTCTTCAACCTTTGAGAAATCCAATCC 
CP025793        GCCTTGGTTTTGGCTTTGAAGCTTCTCTTTTGCTTCTTCAACCTTTGAGAAATCCAATCC 
CP013485        GCCTTGGTTTTGGCTTTGAAGCTTCTCTTTTGCTTCTTCAACCTTTGAGAAATCCAATCC 
                  * **  * ***** ************** *********** ******** ** ** ** 
 
N06_468         CAACTCTTCAACCGCTTCTTTGATTAGCGCAGGGTTTTGCATGACTTGCGCCATCAGCAT 
CP009355        CAACTCATCGACGGCTTCTTTGATTAGCGCAGGGTTTTGCATCACTTGCGCCATCAGCAT 
CP025797        CAACTCGTCTACGGCTTCTTTGATTAGCGCAGGGTTTTGCATCACTTGCGCCATCAGCAT 
CP025793        CAACTCATCTACGGCTTCTTTGATTAGCGCAGGGTTTTGCATCACTTGCGCCATCAGCAT 
CP013485        CAATTCGTCTACCGCTTCTTTGATTAGCGCAGGGTTTTGCATCACTTGCGCCATCAGCAT 
                *** ** ** ** ***************************** ***************** 
 
N06_468         TTGAAGTTTGTCTTGAGGTAAGCCCAATTGACTGATAGTTGCCATTGCAGCAAAAGGGTT 
CP009355        TTGTAGCTTGTCTTGTGGCAGACCTAGTTGGCTGATCGTTGCCATCGCTGCAAGAGGGTT 
CP025797        TTGTAGCTTGTCTTGTGGTAAACCTAGTTGGCTGATTGTTGCCATTGCCGCTAGAGGGTT 
CP025793        TTGTAGCTTGTCTTGTGGCAAACCTAGTTGGCTGATTGTTGCCATTGCCGCTAGAGGGTT 
CP013485        TTGTAGCTTGTCTTGTGGCAAGCCTAGTTGGCTGATTGTTGCCATTGCCGCTAGAGGGTT 
                *** ** ******** ** *  ** * *** ***** ******** ** ** * ****** 
 
N06_468         TTGTGTCAGAGTCTGAAAAATCTCGTTGATTTGTGCGTCTC 
CP009355        TTGCGTCAGAGTTTGGAAGATTTCGTTGATCTGTTCATCGC 
CP025797        TTGCGTCAGAGTCTGAAAAATCTCGTTGATTTGCTCATCGC 
CP025793        TTGCGTCAGAGTCTGAAAAATCTCGTTGATTTGCTCATCGC 
CP013485        TTGCGTCAGAGTCTGAAAAATCTCGTTGATTTGTTCGTCGC 
                              *** ******** ** ** ** ******** **  * ** * 
Figure 3: Multi-alignment of N06-450 marker with other Vibrio sequences. CP009355, V. tubiashii ATCC 19109; CP025797, V. 









                     Advancements in Life Sciences  |  www.als-journal.com  |  August 2020  | Volume 7  |  Issue 4                        261           
 
Development of a diagnostic scar marker for Vibrio shilonii caused acute hepatopancreatic necrosis 
disease in whiteleg shrimp 
You’re reading 
als 
amplification of all samples. Specific PCR products 
generated from these 11 primers were used to screen 
specific markers for V. shilonii. Results showed that the 
12 specific bands were present in five strains of V. 
shilonii and absent in other Vibrio species (Figure 2). Of 
12 PCR products, N06-450 fragment (designated as the 
primer name and expected size of the band) was chosen 
to develop the SCAR marker because it produced a clear 
band of the suitable size (~450 bp) and was sufficiently 
different from RAPD patterns of other pathogens. 
However, the OPN-06 primer amplified only one PCR 
product, so further research was easily performed with 
this band. 
SCAR marker development 
The N06-450 band was chosen to develop the SCAR 
marker. Thus, the PCR band was cloned into pGEM-T 
Easy vector and performed DNA sequencing. The 
results indicated that the length of the amplicon was 468 
bp with 44.4% GC content (A = 119, T = 141, G = 111, 
and C = 97) (Figure 3). 
BLAST results showed no significant similar sequence 
on Genbank database. The similarity coefficient of the 
N06-450 sequence with other Vibrio species ranged from 
74%–78%: V. alginolyticus ATCC 33787 (78.19%), V. 
hyugaensis 090810a (74.13%), V. tubiashii ATCC 19109 
(73.52%), V. owensii 051011B (73.53%), or V. jasicida 
090810c (72.75%) (Figure 3). No similar sequences 
were found from popular Vibrio pathogens such as V. 
parahaemolyticus, V. brasiliensis, V. communis, V. 
furnissii, and V. harveyi. 
The primer pair Vshi-441F/Vshi-441R (Table 3) was 
designed based on the comparison of N06-450 
sequences and others from Genbank (Figure 3 and 
Table 3). The Vshi-441F/Vshi-441R primers were 
selected to amplify on genomic DNA of pathogenic Vibrio 
isolates. A unique band with the size approximately of 
441 bp was observed in V. shilonii isolates only (Figure 
4), indicating that the designed SCAR marker was 
specific for this species, (this SCAR marker was named 
N6-441). 
Primer name Sequence Product length 
Vshi-441F 5’-GTTACGCGGAAAATGTCGGT-3’ 441 bp 
Vshi-441R 5’-GAGACGCACAAATCAACGAG-3’ 
Table 3: Sequences of SCAR primers. 
 
Figure 4: Specific SCAR marker test. M. DNA molecular size 
marker (GeneRulerTM DNA 1 kb ladder, Thermo Fisher 
Scientific). Lane 0, negative control; lane 1, V. parahaemoliticus; 
lane 2, V. vulnificus; lane 3-7, V. shilonii; lane 8, V. cholera; lane 9, 
V. harveyi; lane 10, V. communis; lane 11, V. furnissii; lane 12, V. 
brasiliensis. 
 
Figure 5: Sensitivity test of SCAR primers. M. DNA molecular 
size marker (GeneRulerTM DNA 1 kb ladder, Thermo Fisher 
Scientific). lane 1: 10 ng/μL; lane 2: 5 ng/μL; lane 3: 1 ng/μL; lane 
4: 0.5 ng/μL; lane 5: 0.1 ng/μL; lane 6: 0.01 ng/μL; lane 7: negative 
control. 
To evaluate the SCAR marker sensitivity for V. shilonii 
identification, serial diluted V. shilonii genomic DNA were 
used as templates for the PCR assay using Vshi-
441F/Vshi-441R primers. The results revealed that this 
SCAR marker detected V. shilonii DNA at concentration 
of 100 pg/μL or higher (Figure 5). 
 
Discussion 
Vibrio spp. have been traditionally identified by culture 
the isolate on selective blood agar medium in integration 
with biochemical and serological testing. These methods 
are simple but require a lot of time and technicians. 
Meanwhile, PCR method has high advantages for rapid 
identification of Vibrio spp. in laboratory targeting the 
defined DNA sequences on genomic DNA. Furthermore, 
this method is often selected to amplify the specific 
targeted DNA sequence of the heterogeneous collection 
[14]. 
RAPD is a PCR-based technique to amplify the target 
or random DNA fragment using random primers. RAPDs 
are simple assay with fast results. This technique does 
not require sequence data as well as randomly genome 
distribution, and nature dominant. RAPD marker 
disadvantage is that this method is not able to identify 
the organism species due to their low reproducibility and 
nature dominant. Thus, RAPD marker recently is being 
developed into a codominant and reproducible marker 
(SCAR), which is able for species identification [15]. 
Using SCAR markers for identification of animal 
pathogens has been reported for such pathogens as 
Eimeria species [9] and Actinobacillus 
pleuropneumoniae [16]. 
Molecular diagnostic methods for Vibrio spp. detection 
based on PCR have been reported including loop-
mediated isothermal amplification assay for V. 
parahaemolyticus [17], multiplex PCR for Vibrio spp. 
[18], or V. vulnificus [19]. Conventional PCR for specific 
Vibrio spp. genes also have been reported [20]. 
However, to our knowledge, no SCAR marker methods 
for diagnosing Vibrio spp. have been published 
heretofore. 
In this study, we developed a rapid and highly specific 
SCAR marker for V. shilonii identification and detection. 
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The method was developed based on specific primers 
designed for conventional PCR which is able to replace 
the traditional microbiology method. Our newly 
developed method is applicable for epidemiological 
studies as well as contribution to the protection programs 
for aquaculture. 
Using the RAPD technique, we found a high diversity 
of Vibrio species except for V. shilonii, which is crucial for 
specific DNA fragments selection of the species. The 
designed primers for V. shilonii was evaluated the 
specificity by sequencing the amplified regions, followed 
by BLAST analysis because these sequences did not 
show significant similarities within the NCBI database 
(Figure 3). 
The results in this study therefore show the SCAR 
primers can be applied to directly detect V. shilonii 
strains. The specificity of these primers was evaluated 
based on genomic DNA from eight Vibrio spp. 
demonstrated the positive amplification only observed on 
DNA of the targeted species. 
The results of this study show a high level of 
polymorphism in the RAPD pattern of the different Vibrio 
species, and a SCAR marker (N6-441) was developed 
based on the 468-bp sequence specific to V. shilonii. 
Specific primers (Vshi-441F/Vshi-441R) amplified an 
unique DNA fragment for all V. shilonii isolates but not in 
the other Vibrio spp. This PCR method was highly 
sensitive to the V. shilonii genome and thus may be 
useful in rapid detection of this pathogenic bacterium.  
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